doc`Regenerative Medicine: Achievements and Perspectives`
download 
Report Transcription
FIRST ANNOUNCEMENT WITH PRELIMINARY PROGRAMME DRUŠTVO ZA CELIČNO IN TKIVNO INŽENIRSTVO SLOVENIJE (DCTIS)/ CELL AND TISSUE ENGINEERING SOCIETY OF SLOVENIA (CTESS) organizes the SCIENTIFIC SYMPOSIUM WITH INTERNATIONAL PARTICIPATION 'Regenerative Medicine: Achievements and Perspectives' DATE AND VENUE: 17 April 2015, 9.00 am to 6.00 pm Department of Orthopaedic Surgery, University Medical Centre, Ljubljana GOALS: The aim of the symposium is to bring together and accelerate the cooperation between clinicians, researchers, companies and regulatory bodies in order to advance the field of regenerative medicine, with the following main goals: § § § presenting the results of the latest research studies in the field of the regenerative medicine, strengthening cooperation between Slovene and European experts, transferring knowledge and experience between research and clinical practice. PRELIMINARY PROGRAMME: The meeting will include plenary lecture and four oral sessions. Each oral session will include invited speakers and speakers selected from submitted abstracts. The final programme will be announced on 2 April 2015. PLENARY LECTURE: "Tissue repair: from Tissue Engineering to Regenerative Medicine" /prof Ranieri Cancedda, MD/ SESSION I: Clinical research SESSION II: Pre-clinical and in vitro research SESSION III: Biomaterials and drugs in regenerative medicine SESSION IV: Technology, ethical, and regulatory aspects of the use of cells and tissues for medical treatments AMONG INVITED SPEAKERS The world's most renowned scientists in their respective fields confirmed the attendance: Prof Ranieri Cancedda, MD - Expert in the area of: molecular and cell biology of cartilage and bone; tissue engineering and regenerative medicine of skeletal tissue; osteobiology in microgravity Professor of Cell Biology and Dean of the Biotechnology School at the University of Genova, Italy Head of the Laboratory of Regenerative Medicine of the San Martino-IST National Cancer Research Institute, Genova, Italy Co-founder and the first President of the European Tissue Engineering Society (ETES), now Tissue Engineering and Regenerative Medicine International Society (TERMIS) Prof Jennifer Southgate - Expert in the area of: urothelial tissue models, bladder tissue engineering, bladder carcinogenesis Professor of Molecular Carcinogenesis and Director of the Jack Birch Unit of Molecular Carcinogenesis, Department of Biology, University of York, UK Co-founder of Histotech and Kystis as University-embedded, industry-facing research contract organisations Francesco Perdisa, MD, Phd - Expert in the area of: orthopedic surgery; arthroscopy; tissue engineering based knee reconstruction Orthopedic surgeon at Rizzoli Orthopaedic Institute, Bologna, Italy The updated list of confirmed speakers will be available at www.dctis.si REGISTRATION AND FEES: Registration is required for all symposium participants. Please complete the registration form and send it to the e-mail address: [email protected], before 10 April 2015. Please be aware that the number of participants is limited, so apply early. The registration fee includes attendance to all lectures, badge, printed book of abstracts, coffee breaks. REGISTRATION FEE Employed Young researchers/ medical practitioners Students CTESS (DCTIS) member (paid membership for 2015) 50,00 EUR 15,00 EUR Non members 0,00 EUR 0,00 EUR 70,00 EUR 35,00 EUR ABSTRACT SUBMISSION: Participants interested in presenting their work are invited to submit an abstract, which should fall into one of the four topics of the symposium. The abstract template is provided in the attachment. All abstracts will undergo peer review by the scientific committee, and may be accepted for oral presentation, publication in the book of abstracts, or rejected. CTESS intends to issue a peer reviewed scientific monography entitled “Regenerative Medicine: Achievements and Perspectives” with full-length research or review papers (proceedings of the symposium). The decision for publication of the proceedings will be based on expressed interest of the potential authors. Therefore, we kindly ask you to declare in the registration form your intention to prepare and submit a paper to the “Regenerative Medicine: Achievements and Perspectives” proceedings. IMPORTANT DATES: Abstract submission Information to authors about acceptance of abstracts for oral presentation The final programme announced Registration 25 March 2015 2 April 2015 2 April 2015 10 April 2015 LANGUAGE: English INVITATION TO SPONSORSHIP: The CTESS Symposium ‘'Regenerative Medicine: Achievements and Perspectives' will bring together broad national and international tissue engineering community, and is therefore an excellent opportunity to present your business and connect with clinical doctors and scientists. There will be dedicated exhibition area and various options for advertising your company and sponsorship the event. For more information, please contact: [email protected] ADDITIONAL INFORMATION: e-mail: [email protected], web: www.dctis.si ORGANIZING AND SCIENTIFIC COMMITTEE: Mirjam Fröhlich, PhD, Jozef Stefan Institute; Educell, Slovenia (President) Damjan Radosavljević, MD, Medical Centre Ljubljana, Slovenia (President of CTESS) Assist Prof Nevenka Kregar Velikonja, Faculty of Health Sciences Novo mesto; Educell Slovenia Assist Prof Elvira Maličev, Blood Transfusion Centre of Slovenia; Biotechnical Faculty, University of Ljubljana Assoc Prof Mateja Erdani Kreft, Institute of Cell Biology, Faculty of Medicine, University of Ljubljana Katerina Čeh, PhD, Animacel Assist Prof Miomir Knežević, Educell; Biobanka; Biotechnical Faculty, University of Ljubljana Helena Motaln, PhD, National Institute of Biology, Ljubljana, Slovenia Assist Prof Matej Drobnič, MD, University Medical Centre Ljubljana, Slovenia
Similar documents
Market Overview – Regenerative Medicine Market Shares, Strategies And Forecasts to 2023: Credence Research
Credence Research has recently issued a new market assessment report titled “Regenerative Medicine – Growth, Future Prospects and Competitive Analysis, 2016 – 2022”. The global Regenerative Medicine Market study provides a comprehensive view of the ongoing and future phases of the Regenerative Medicine industry based on parameters such as major commercial events, research initiatives, government guidelines, market drivers, restraints and opportunities and detailed industry segmentation and regional distribution.
Browse the report at http://www.credenceresearch.com/report/regenerative-medicine-market
Based on geographic/regional distribution the global Regenerative Medicine Market is studied for key regional markets focusing on the respective geographic trends and statistics, and thereby delivering market size and forecast values. The Regenerative Medicine Market based on geographic classification is studied for North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa markets. Among these, the North America, Europe and Asia-Pacific Regenerative Medicine Market is studied for top country-level markets. The Regenerative Medicine industry in each individual country market is studied based on parameters such as per capita income, population, gross domestic product (GDP), status of infrastructure, purchasing power parity, etc. Technology development, industry concentration, end-user preference, and similar such grounds are also considered while estimating the market for Regenerative Medicine. The market estimates are provided for the period 2014-2022, along with corresponding compounded annual growth rates (CAGRs) for the forecast period 2016-2022.
Request Table of content - http://www.credenceresearch.com/request-table-of-content/58213
This report on Regenerative Medicine Market also offers competition assessment tools such as market positioning of key players, attractive investment proposition, and Porter’s Five Forces model to give the readers a view of the competitive scenario of the Regenerative Medicine Market. The Regenerative Medicine Market report is concluded with company profiles chapter. This section highlights major information about the key players engaged in development, manufacture, distribution and sale of Regenerative Medicine in the international markets.
Request free sample - http://www.credenceresearch.com/sample-request/58213
Major extracts from the Table of Content of Regenerative Medicine Market, 2016-2022 report:
Regenerative Medicine Market Dynamics – Drivers, Challenges, Opportunities
Regenerative Medicine Market Size and Forecast for the Period 2014-2022
Regenerative Medicine Market CAGR for the Period 2016-2022
Regenerative Medicine Market Competitive Analysis, by Key Players
Regenerative Medicine Market: Attractive Investment Proposition, by Geography
Regenerative Medicine Market: Key Commercial Events
Regenerative Medicine Market: Future Prospects (upcoming product approvals)
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: [email protected]
Ph: 1-800-361-8290
Web: http://www.credenceresearch.com
Global Regenerative Medicine Market
Regenerative medicine is a category of research in tissue engineering and molecular biology which deals with the method for human cells, tissues and organs reco nstruction to reactivate normal body function. The regenerative medicine repairs the defective cells and tissues. Regenerative medicine treats the basic cause of disease, injuries and genetic conditions. Regenerative medicine gives complete treatment of the abnormality or disease as compared to the symptomatic treatments. Regenerative medicine is a treatment technique which works in three approaches which ensure the complete eradication of the injury of the cell, tissue or organ. There are stem cells and non-stem cell (somatic) therapies which includes taking cells from healthy body organ in the body and applying these cells to the damaged area after expanding these cells in cell culture.
Global Regenerative Therapies Market, 2016 to 2022
The global regenerative therapies market has been estimated to be valued at US$ 5,286.2 Mn by the end of 2015, and is projected to witness stable growth across all global regions, which is attributed to the rising demand for fulfilling unmet clinical needs for longer sustainability and faster outcome treatments within a shorter time span.
